26 / 39
Quality of Life and Overall Survival in
Patients With Advanced Clear-Cell
Renal Cell Carcinoma Treated With
Nivolumab Versus Everolimus in
the Phase III CheckMate 025 Study
David Cella,
1
Viktor Grünwald,
2
Paul Nathan,
3
Justin Doan,
4
Homa Dastani,
4
Fiona Taylor,
5
Bryan Bennett,
6
Michael DeRosa,
5
Scott Berry,
7
Kristine Broglio,
7
Elmer Berghorn,
4
Robert J. Motzer,
8
1
Northwestern University, Chicago, IL, USA;
2
Hannover Medical School, Hannover, Lower Saxony, Germany;
3
Mount Vernon Cancer Centre, Middlesex, UK;
4
Bristol-Myers Squibb, Princeton, NJ, USA;
5
Adelphi Values, Boston, MA, USA;
6
Adelphi Values, Bollington, Cheshire, UK;
7
Berry Consultants, Austin, TX, USA;
8
Memorial Sloan Kettering Cancer Center, New York, NY, USA